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on erythromycin (1.0 g/day) and
quickly responded to this treatment
without administration of diphtheria
antiserum. Erythromycin was intra-
venously administered at 1 g per day
for 9 days, then orally administered at
1,200 mg per day for the next 14 days.
Throughout the hospitalization, no
complication occurred, and no abnor-
malities were noted in the electrocar-
diograms or in the patient’s neurolog-
ic status. The patient was discharged
uneventfully, and no serious sequelae
were noted for 20 months. History of
immunization for diphtheria was not
known.
After the hospitalization for this
acute illness, a laboratory report
showed that C. ulcerans was cultured
from the thick white coat of the throat.
No other bacteria were found. The
National Institute of Infectious
Diseases in Tokyo later confirmed
identification of the bacteria. By using
Elek’s test, Vero cell toxicity, and
polymerase chain reaction for toxi-
gene, this strain of C. ulcerans was
proven to produce diphtheria toxin
identical to C. diphtheriae (2–4).
Although administering appropriate
antibiotics as well as antitoxin is a
standard of care for patients with
diphtheria, antitoxin was not given to
this patient because of her rapid
response to the erythromycin therapy.
C. ulcerans infections in humans
occur after drinking unpasteurized
milk or coming in contact with dairy
animals or their waste (5,6). However,
person-to-person transmission of C.
ulcerans has not been reported, and in
some cases, the route of transmission
is not clear (7). Recently, C. ulcerans-
producing diphtheria toxin was isolat-
ed in the United Kingdom from cats
with nasal discharge (8). 
Our patient did not have direct
contact with dairy livestock or unpas-
teurized dairy products; however,
more than 10 dairy farms are scattered
around her home. Moreover, she kept
nearly 20 cats in her house and had
been scratched by a stray cat a week
before illness developed. This stray
cat, which had rhinorrhea and sneez-
ing, had wandered into her house. The
stray cat died before the patient
became ill, and no further investiga-
tion could be made. Stray cats might
well be one of the possible carriers of
C. ulcerans and might have transmit-
ted the bacteria to this patient. To our
knowledge, a case of human infection
caused by C. ulcerans has never been
reported in Japan. On the basis of cur-
rent experience, this bacterium does
exist in Japan and can potentially
cause a serious diphtheria-like illness
in humans. 
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Salmonella in Birds
Migrating through
Sweden 
To the Editor: To determine how
common  Salmonella infection is in
the migrating wild bird population,
we considered the biology of the bac-
terium and that of its avian hosts.
Previous studies have attempted to
determine in which stages wild birds
become infected, how infections are
acquired, and how this information
should be translated into epidemio-
logic risk assessments for human and
animal health. For instance, most pub-
lished studies originate from small
epizootics and are of either dead birds
at feeding stations (1) or infected
birds in or around barns where the
livestock has Salmonella infection
(2). This bias has important conse-
quences, as the natural prevalence of
Salmonella in the non-epizootic situa-
tion likely is overestimated. Finding
infected birds close to a barn with
infected cattle does not prove that
transmission occurred from the birds
to the animals. In addition, an epizoot-
ic at a feeding station does not prove
that  Salmonella normally occurs in
the inflicted bird species, as the birds
could have became infected through
proximity to the infected animals, or
in the case of the bird feeder, through
feed contaminated from an unknown
source. We need baseline surveillance
data on the prevalence of Salmonella
in non-epizootic situations, in healthy
bird communities and in different754 Emerging Infectious Diseases • Vol. 9, No. 6, June 2003
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stages of a bird’s life (e.g., during
breeding, molting, and migration), to
better understand Salmonella epi-
demiology in relation to wild birds.
We focused on the migratory bird
fauna of the North Western
Palearctic, where most of the birds
migrate south to spend the nonbreed-
ing season in continental Europe and
Africa. In these areas, certain
species, such as gulls, corvids, star-
lings, and thrushes, may overwinter
in agricultural and urban areas were
domestic animals are present. We
sampled apparently healthy birds
trapped on active migration at
Ottenby Bird Observatory (56°12'N,
16°24'E), on the southernmost tip of
the island Öland, southeast Sweden,
during the migration periods
July–November 2001, March–May
2002, and July–December 2002. We
used a standardized trapping and
sampling scheme, previously used at
the same site for large-scale screen-
ing of Campylobacter  infections in
wild birds (3). To apply a random
procedure in selection of species and
persons, every 10th bird banded dur-
ing the migration periods was sam-
pled for Salmonella spp. We did not
sample recaptured birds previously
banded by us.
In total, 2,377 samples from 110
species of migratory birds (1,086
samples in autumn 2001, 777 in
spring 2002, and 514 in autumn 2002)
were analyzed for Salmonella infec-
tions. We applied routine procedures
for isolation of putative Salmonella
isolates, with enrichment in
Rappaport-Vassiliadis broth and
injection into xylose-xysine-desoxy-
cholate (XLD) agar. On this media,
most  Salmonella enterica serotype
Enterica appears as red transparent
colonies with black centers. Colonies
with growth characteristics of
Salmonella were observed in 236
samples, and full phenotypic identifi-
cation was performed on these iso-
lates by using standard biochemical
and serologic testing. By using the
API system (4), the isolates were
identified as Citrobacter youngae, C.
braakii, C. freundii, Escherichia vul-
neris, E. coli, Hafnia alvei, Klebsiella
pneumoniae ozaenae, Acinetobacter
baumanii , Providencia stuartii/ rett-
geri, and Yersinia kristen senii. Only
one of the isolates, obtained from a
Mistle Thrush (Turdus viscivorus) and
sampled during the spring migration
2002, carried Salmonella. This isolate
was characterized by serotyping
according to the Kauffman-White
serotyping scheme (5) at the reference
laboratory of the Swedish Institute for
Infectious Disease Control. The
thrush isolate was identified as S.
Schleissheim, a rare Salmonella
serotype. Human salmonellosis
caused by this serotype has been pre-
viously reported only in Turkey (6).
No reservoir of S.  Schleissheim, in
animals or in humans, has been
reported in Sweden in the last 10
years covered by the current epidemi-
ologic records.
The failure to find Salmonella was
probably not caused by technical
problems. The sampling methods
used, with fecal samples from fresh
droppings or cloacal swabs, are well-
established techniques for studying
Salmonella prevalence in birds
(2,7,8). The laboratory methods used,
with enrichment in Rappaport-
Vassaliadis broth and subsequent cul-
turing on XLD-agar, are extremely
sensitive for detecting Salmonella,
even for samples highly contaminated
with other Enterobacteriaceae (9).
Thus, in this large dataset, only one
Salmonella isolate was found, repre-
senting a serotype rarely observed in
clinical or veterinary samples. In par-
ticular, one serotype, S. Typhimurium
DT40, has been associated with epi-
zootics in wintering passerine birds
(10), but this serotype was not found
in any of our samples. 
Results from our study indicate
that the prevalence of this serotype in
the healthy wild bird population is
low. Our dataset was composed of
many different species, but the num-
ber of tested individual birds for each
species was low in many cases.
Earlier studies have pointed to certain
species (gulls and corvids) in which
the prevalence of Salmonella is some-
times high (2% to 20%), and argued
that concern should be strong about
epidemiologic disease transmission
with these birds (7,8). These species
have the capability to live in an oppor-
tunistic manner in close proximity to
humans and can base their diet on
waste products and garbage. Most
bird species, however, have little or
no niche overlap with humans or
domesticated animals; virtually no
data exists on the occurrence of
Salmonella in this major group of
migrating birds during a non-epizoot-
ic situation. Our results suggest that
the natural occurrence of Salmonella
in healthy birds during migration in
Sweden may be low. Therefore, the
Salmonella incidence is probably also
low for most wild bird species. We
suggest that researchers consider ana-
lyzing the non-epizootic natural
occurrence of Salmonella in wild
birds. Accumulated knowledge from
many different regions, over many
years, is a prerequisite for thorough
risk assessment of the importance of
Salmonella carriage in wild birds. 
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Parachlamydiaceae
as Rare Agents of
Pneumonia 
To the Editor: Members of the
Parachlamydiaceae family are emer-
ging intracellular bacteria living in
amoebae (1,2). Serologic studies have
suggested that Parachlamydia acan-
thamoeba might be an agent of com-
munity-acquired pneumonia transmit-
ted from a water source (3,4). In a sin-
gle occasion, 16s rRNA of a member
of the Parachlamydiaceae family was
amplified and sequenced from a bron-
choalveolar lavage sample (5). Thus,
to specify the role played by the
Parachlamydiaceae as agents of
lower respiratory tract infection, we
developed a real-time polymerase
chain reaction (PCR) assay and
applied it to 1,200 bronchoalveolar
lavage samples, taken mainly from
patients with pneumonia of unknown
cause and received in our diagnostic
microbiology laboratory between
1997 and 2002. 
DNA extraction was performed by
using the MagNAPure LC instrument
and the MagNA Pure LC DNA
Isolation Kit III (Roche Molecular
Biochemicals, Mannheim, Germany).
Real-time PCR was performed by
using TaqMan technology and target-
ing the gene encoding for a nonmito-
chondrial ATP/ADP translocase
(GenBank accession no. AF490592).
This energy parasite gene is present
only in rickettsiae, chlamydiae, and
plant plastids (6). The master mixture
was prepared from the TaqMan
Universal Master Mix kit (Applied
Biosystems, Foster City, CA), accord-
ing to the manufacturer’s instructions,
and included 200 nM of each primer
(Adp81F 5´- TAGTGATCTGC-
TACGGGATTT, Adp84R 5´-TTG-
GATTAGGATATTGCAATTT) and
200 nM of the fluorescent labeled
probe (6-FAM-5´-AACCTTGTA-
GAAGTAACCTGGAA-
GAACCAGC-3´-TAMRA, where 6-
FAM is 6-carboxyfluorescein and
TAMRA is 6-carboxytetramethylrho-
damine). Amplification was carried
out on the ABI 7700 sequence detec-
tion system (TaqMan system, Applied
Biosystems), by running 45 cycles,
with annealing temperature of 52°C
and polymerization temperature of
60°C. To prevent carryover, 200 µ M
of uracil triphosphate was part of the
master mixture, and uracil-N-glycosy-
lase was used systematically. Para-
chlamydia acanthamoeba strain Hall
coccus (kindly provided by T.J.
Rowbotham) (3) and sterile water
were used as positive and negative
controls, respectively. In addition,
PCR was tested on Chlamydophila
pneumoniae and  Chlamydia psitacci
and four strains of Rickettsia. All but
one (Rickettsia montana) was nega-
tive, as were 64 sterile water controls. 
Of the 1,200 bronchoalveolar
lavage samples tested, 5 (0.42%) were
positive. When PCR was repeated for
those five samples, four were negative
for P. acanthamoeba DNA, and only
one was a true positive, confirmed by
sequencing the product of the addi-
tional PCR. The sequence shared
100% DNA homology with P. acan-
thamoeba strain Hall coccus
(GenBank accession no. AF490592).
The patient, a 31-year-old man who
was HIV-positive, had pneumonia,
cough, and no fever. Chest x-ray
examination showed an opacity in the
right lung and a bilateral infiltrate.
Leukocyte count was 5,000/mm3 with
80 CD4 cells/mm3; microbiologic
investigations (in which the bron-
choalveolar lavage was examined for
cytomegalovirus,  Chlamydophila
pneumoniae,  Legionella pneumo-
phila,  Pneumocystis carinii,  myco-
bacteria, and Toxoplasma gondii) did
not identify a causal agent. 
We developed a highly sensitive
PCR, which could amplify as few as
10 bacteria. The assay results in a rel-
atively high specificity (1,195/ 1,199;
99.67%) because it uses a target gene
found only in Rickettsiae,